It is difficult to estimate the impact of Bowel Incontinence or BCD (Bowel Control Disorder) on patients, families and our health care system. It's a debilitating and isolating illness that's embarrassing for patients to talk about – even to their doctors. This condition remains dramatically under-reported.
Here's what we do know:
- Bowel incontinence affects approximately 18 million adults in the United States
- The stigma of the disease is overwhelming and results in depression, anxiety and social isolation
- Bowel incontience is the second leading cause of admittance to nursing homes in the US
- Up to 30% of women who have given birth have some level of BCD
- In males, incontinence is frequently associated with local injury or disease
- Only 20% of patients ever speak to their doctor about their condition
Bowel incontinence is classified as active (patient aware) or passive (patient unaware). Cause of bowel incontinence may include:
- Anal sphincter weakness
- Anal sphincter injury
- Pudendal nerve injury
- Rectal prolapse
- Neurological problems
We will only be able to uncover the true prevalence of bowel incontinence when patients are made aware of all available therapies and doctors make questions about bowel control part of their standard work up, especially for women.
In recent years minimally invasive therapies give new hope to patients with BCD, among those is Secca Therapy. Secca has a history of safety and effectiveness and fills the treatment gap for patients who have failed conservative therapies and are concerned about invasive surgical options.